NZ512835A - Genes identified as required for proliferation in escherichia coli - Google Patents

Genes identified as required for proliferation in escherichia coli

Info

Publication number
NZ512835A
NZ512835A NZ512835A NZ51283500A NZ512835A NZ 512835 A NZ512835 A NZ 512835A NZ 512835 A NZ512835 A NZ 512835A NZ 51283500 A NZ51283500 A NZ 51283500A NZ 512835 A NZ512835 A NZ 512835A
Authority
NZ
New Zealand
Prior art keywords
proliferation
polypeptide
seq
nucleic acid
escherichia coli
Prior art date
Application number
NZ512835A
Other languages
English (en)
Inventor
R Allyn Forsyth
Judith Zyskind
Kari L Ohlsen
Original Assignee
Elitra Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elitra Pharmaceuticals Inc filed Critical Elitra Pharmaceuticals Inc
Publication of NZ512835A publication Critical patent/NZ512835A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NZ512835A 1999-01-27 2000-01-27 Genes identified as required for proliferation in escherichia coli NZ512835A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11740599P 1999-01-27 1999-01-27
PCT/US2000/002200 WO2000044906A2 (en) 1999-01-27 2000-01-27 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI)

Publications (1)

Publication Number Publication Date
NZ512835A true NZ512835A (en) 2004-02-27

Family

ID=22372748

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ512835A NZ512835A (en) 1999-01-27 2000-01-27 Genes identified as required for proliferation in escherichia coli

Country Status (7)

Country Link
EP (1) EP1149166A2 (xx)
JP (1) JP2002535007A (xx)
KR (1) KR20010101861A (xx)
AU (1) AU3584500A (xx)
CA (1) CA2360085A1 (xx)
NZ (1) NZ512835A (xx)
WO (1) WO2000044906A2 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1396543A3 (en) * 1999-07-08 2004-03-31 Research Association for Biotechnology Primers for synthesizing full length cDNA clones and their use
WO2001027262A1 (en) * 1999-10-13 2001-04-19 Pantheco A/S Gene selection using pnas
US6783985B1 (en) 2000-02-18 2004-08-31 Elitra Pharmaceuticals Inc. Gene disruption methodologies for drug target discovery
WO2002079467A2 (en) * 2001-03-29 2002-10-10 Københavns Universitet Antibiotic-free bacterial strain selection with antisense molecules
AU2002355155A1 (en) * 2001-07-24 2003-02-17 Affinium Pharmaceuticals Inc. Methods for gene disruption and uses thereof
FR2842210B1 (fr) * 2002-07-09 2012-12-14 Mutabilis Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique
JPWO2007013411A1 (ja) * 2005-07-25 2009-02-05 株式会社カネカ 生物由来のアンチセンス核酸
CA2620577A1 (en) * 2005-09-01 2007-03-08 The Feinstein Institute For Medical Research Peptide mimics of melanocyte stimulating hormone
EP2482836B1 (en) * 2009-10-02 2016-04-13 Oslo Universitetssykehus HF Antibacterial polypeptides and use thereof
US9090928B2 (en) * 2010-10-07 2015-07-28 Yale University Site-specific incorporation of phosphoserine into proteins in Escherichia coli
WO2013009868A1 (en) 2011-07-11 2013-01-17 Yale University Compositions and methods for making selenocysteine containing polypeptides
US10240158B2 (en) 2011-07-11 2019-03-26 Yale University Compositions and methods for making selenocysteine containing polypeptides
US11788111B2 (en) 2011-07-11 2023-10-17 Yale University Compositions and methods for making selenocysteine containing polypeptides
US10876142B2 (en) 2011-07-11 2020-12-29 Yale University Compositions and methods for making selenocysteine containing polypeptides
WO2020158877A1 (ja) * 2019-01-31 2020-08-06 Ｓｐｉｂｅｒ株式会社 組換えタンパク質の製造方法
CN113917140B (zh) * 2021-10-28 2023-08-18 生工生物工程（上海）股份有限公司 一种快速筛选原核蛋白表达菌的方法
US11866728B2 (en) 2022-01-21 2024-01-09 Renagade Therapeutics Management Inc. Engineered retrons and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5442198A (en) * 1996-11-13 1998-06-03 Q.B.I. Enterprises Ltd. Gene identification method
US6610539B1 (en) * 1997-07-10 2003-08-26 Genesense Technologies, Inc. Antisense oligonucleotide sequences as inhibitors of microorganisms

Also Published As

Publication number Publication date
EP1149166A2 (en) 2001-10-31
CA2360085A1 (en) 2000-08-03
KR20010101861A (ko) 2001-11-15
JP2002535007A (ja) 2002-10-22
WO2000044906A3 (en) 2001-02-01
WO2000044906A2 (en) 2000-08-03
AU3584500A (en) 2000-08-18

Similar Documents

Publication Publication Date Title
NZ512835A (en) Genes identified as required for proliferation in escherichia coli
CA2300358A1 (en) Novel phytase
AU2875492A (en) Recombinant core-streptavidin
HUP9900868A2 (hu) Heterológ gének kromoszomális expressziója bakteriális sejtekben
IL129722A0 (en) Method for the production of 1,3-propanediol by recombinant organisms
ATE93867T1 (de) Rekombinante dns-vektoren faehig zur apoaequorinexpression, apoaequorinpeptide und deren herstellung und diese vektoren enthaltende mikroorganismen.
Künzler et al. Pathological, physiological, and evolutionary aspects of short unstable DNA repeats in the human genome
EP1657256A3 (en) Compositions and methods for the treatment of tumor
CA2327266A1 (en) Pesticidal toxins and nucleotide sequences which encode these toxins
JP2002513574A5 (xx)
CA2252493A1 (en) .beta.-galactoside - .alpha. 2,6-sialyltransferase gene
AU6724794A (en) GRB3-3 gene, its variants and their uses
EP0780471A3 (en) Novel nitrilase gene
ZA200102385B (en) Nucleotide sequences coding for the dapC gene and process for the production of L-lysine.
Santa Maria et al. Identification of microbial dimethylarginine dimethylaminohydrolase enzymes.
Parquet et al. Nucleotide sequence of the murF gene encoding the UDP-MurNAc-pentapeptide synthetase of Escherichia coli.
EP1476462A4 (en) NEW LIPASE FROM MUSHROOMS
CA2384122A1 (en) Cyclic depsipeptide synthetase and gene thereof, and mass production system for cyclic depsipeptide
EP1047710B1 (de) Orotidin-5'-phosphatdecarboxylase-gen, genkonstrukt enthaltend dieses gen und seine verwendung
WO2002010384A1 (fr) Genes codant des proteines capables de regenerer la luciferine, adn recombine et methode de production de proteines capables de regenerer la luciferine
AU2003219134A1 (en) Identification of 3-ketosteroid 9-alfa-hydroxylase genes and microorganisms blocked in 3-ketosteroid 9-alfa-hydroxylase activity
GB9615498D0 (en) Kinase
CA2103248A1 (en) Novel bacillus thuringiensis isolates active against hymenopteran pests and genes encoding hymenopteran-active toxins
Ivey Nucleotide sequence of a gene from alkaliphilic Bacillus firmus RAB that is homologous to the fpg gene of Escherichia coli
GB9724627D0 (en) Gram positive microorganism formate pathway

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed